Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: EMERGENT PRODUCT DEVELOPMENT GAITHERSBURG INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2014-08-28 to 2024-02-29
Current total value of award: $30177860.81
Description: DEVELOPMENT OF VACCINE FORMULATIONS EFFECTIVE AGAINST NIAID PRIORITY PATHOGENS